Synapse - Carl Landgren

Search Within

Carl Ola Landgren

Results (336)

Donor-specific antibodies, immunoglobulin-free light chains, and BAFF levels in relation to risk of late-onset PTLD in liver recipients

Journal Article

Engels, E. A.; Jennings, L. W.; Everly, M. J.; Landgren, O.; Murata, K.; Yanik, E. L.; Pfeiffer, R. M.; Onaca, N.; Klintmalm, G. B.
Transplantation Direct (2018)

Fulltext@MSK | Save

Peripheral neuropathy is associated with an increased risk of fractures in individuals with monoclonal gammopathy of undetermined significance: A population-based study including 15,351 MGUS cases

Meeting Abstract

Rognvaldsson, S.; Thorsteinsdottir, S.; Turesson, I.; Bjorkholm, M.; Landgren, O.; Kristinsson, S. Y.
Blood (2018)

Fulltext@MSK | Save

Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial

Meeting Abstract

Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
Blood (2018)

Fulltext@MSK | Save

Carfilzomib-lenalidomide-dexamethasone versus bortezomib-lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma: Results from the prospective, longitudinal, observational CoMMpass study

Meeting Abstract

Landgren, O.; Siegel, D. S.; Auclair, D.; Chari, A.; Boedigheimer, M.; Welliver, T.; Mezzi, K.; Iskander, K.; Jakubowiak, A.
Blood (2018)

Fulltext@MSK | Save

Updated results from the phase 2 CENTAURUS study of daratumumab (DARA) monotherapy in patients with intermediate-risk or high-risk smoldering multiple myeloma (SMM)

Meeting Abstract

Landgren, O.; Cavo, M.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P. M.; Estell, J.; Sandhu, I.; Jenner, M.; Williams, C.; more...
Blood (2018)

Fulltext@MSK | Save

MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone

Meeting Abstract

Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
Blood (2018)

Fulltext@MSK | Save

Mytype: A capture based sequencing approach to detect somatic mutations, copy number changes and IGH translocations in multiple myeloma

Meeting Abstract

Yellapantula, V.; Hultcrantz, M.; Rustad, E. H.; Landau, H. J.; Iacobuzio-Donahue, C.; Akhlaghi, T.; Amit, I.; Ledergor, G.; Korde, N.; Mailankody, S.; more...
Blood (2018)

Fulltext@MSK | Save

Whole genome sequencing of extramedullary myeloma autopsy tumors reveals a genomic portrait at culmination of clonal convergence

Meeting Abstract

Yellapantula, V. D.; Rustad, E. H.; Glozdik, D.; Gundem, G.; Fan, J.; Medina, J.; Patel, A.; Patel, M.; Hultcrantz, M.; Peled, J. U.; more...
Blood (2018)

Fulltext@MSK | Save

The impact of fractures on survival in multiple myeloma: Results from a population-based study

Meeting Abstract

Thorsteinsdottir, S.; Sverrisdottir, I. S.; Gislason, G.; Landgren, O.; Turesson, I.; Bjorkholm, M.; Kristinsson, S. Y.
Blood (2018)

Fulltext@MSK | Save

Measurement of serum microRNAs in US veterans with monoclonal gammopathy of undetermined significance

Meeting Abstract

Wang, W.; Shim, Y. K.; Michalek, J. E.; Barber, E.; Saleh, L. M.; Choi, B. Y.; Wang, C. P.; Ketchum, N.; Costello, R.; Marti, G. E.; more...
Blood (2018)

Fulltext@MSK | Save